Updated on 4 March 2015
Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, announced that its ResolutionMD medical imaging software has received Class II certification from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for diagnosis using both web and mobile devices for all imaging modalities.
This certification enables medical practitioners to take advantage of the benefits of quick, mobile access to images as they can now access a range of image storage systems and diagnostic tool sets from any location.
ResolutionMD enables doctors to securely view patient images and reports from a wide variety of computers and mobile devices; collaborate with other practitioners and diagnose from any location.
The company believes that by obtaining the certificate from the Japanese PMDA means that healthcare organizations in Japan can now feel confident using ResolutionMD, which is claimed to be the world's leading enterprise image-viewing solution, to perform a clinical diagnosis using web, iOS or Android devices. The PMDA certificate follows the FDA Class II clearance in the US, CFDA certification in China, CE marking in Europe, TGA certificate in Australia and Health Canada license.
The PMDA certified mobile medical diagnosis software can be integrated into any EMR and easily plugs into existing distributed storage systems. ResolutionMD's federated approach is an important differentiator from other solutions as highly sensitive data is never moved to a device and no additional data storage locations are created.
ResolutionMD is currently installed in leading healthcare institutions around the world via a network of more than forty-five world class healthcare partners.